• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
AMRA MedicalAMRA Medical

AMRA Medical

Precision for Decision

  • Career
  • Support
  • Contact Us
  • Solutions
    • Clinical Services
    • Research Services
  • Get Set Up
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Media
  • About Us
    • About AMRA
    • Our Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us

Muscle-Liver Crosstalk and Sarcopenia in Chronic Liver Disease – Novel Techniques and Clinical Evidence

You need a link to access the webinar

You will get an access link sent to your e-mail.

Recent studies highlight an important and independent relationship between sarcopenia and chronic liver diseases, particularly non-alcoholic fatty liver disease (NAFLD). While the impact of sarcopenia in patients with end-stage liver disease (ESLD) or decompensated cirrhosis is well established, emerging data underscores the importance of detecting sarcopenia in patients with early NAFLD.

Current muscle-based sarcopenia definitions fail to detect sarcopenia in the population with obesity, which is overrepresented in NAFLD. Until recently, the skeletal muscle-liver crosstalk and the impact of interventions on skeletal muscle have been largely overlooked in the research for NAFLD treatments. Growing evidence places skeletal muscles’ impact on insulin resistance and systemic inflammation at the center of the NAFLD pathogenic cascade.

In this webinar, experts in liver and metabolic diseases, and imaging, will review the latest research on how to assess and monitor sarcopenia in chronic liver disease. Research regarding how sarcopenia may impact chronic liver disease treatment, the current pathophysiological mechanisms linking skeletal muscle metabolism and sarcopenia to liver disease, and how these may be used to discover and develop new treatments will be explored. Finally, they will also discuss how rapid whole-body magnetic resonance imaging (MRI) has been utilized for quantitative, standardized, and objective body composition assessments in recent sarcopenia research:

Manu V. Chakravarthy, MD, PhD, Axcella Health Inc. – Muscle-liver crosstalk – why focusing on the muscles might be the key to treat liver disease

Mohammad Shadab Siddiqui, MD, Virginia Commonwealth University – Sarcopenia after liver transplant and its impact on cardiometabolic health – assessment, treatment, and implications​​

Mikael F. Forsgren, PhD, AMRA Medical Research – MRI for body composition and sarcopenia in chronic liver disease research

Primary Sidebar

  • Facebook
  • Twitter
  • LinkedIn
  • Mail
WEBINAR DATE

8 December 2020

avatar
Manu Chakravarthy, MD, Ph.D.

Executive Vice President of Clinical Development, Chief Medical Officer

Read more
avatar
Mohammad Shadab Siddiqui, MD

Associate Professor of Medicine at Virginia Commonwealth University in Richmond

Read more
avatar
Mikael Forsgren, Ph.D.

Senior Scientist, Liver Disease Lead Scientist

Read more
What you will learn
  • After liver transplant, sarcopenia and metabolic health assessment, treatment and implications
  • In addition to following the liver, what is the benefit of focusing on the muscles in clinical research
  • The use of MRI to follow muscles and body composition in patients being treated for liver disease
Who should attend?
  • Chief Medical Officer
  • Chief Executive Officer
  • Principal Investigator
  • Medical Director
  • Research Nurse
  • Clinical Director
  • Clinical Project Manager
  • Imaging Specialist
  • Clinical Operations
  • Clinical Development Manager
  • Procurement Manager
  • Statistician
  • Data Manager
  • Regulatory Coordinator
  • Business Development
AMRA Medical
Follow us

About

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

  • Data Privacy Policy
  • Cookie Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support

Newsletter

© 2025 AMRA Medical AB
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}